Effects of Computed Tomography Hyperdense Middle Cerebral Artery Sign on the Efficacy of Endovascular Therapy in Acute Ischemic Stroke With Large Infarcts: A Subgroup Analysis of the ANGEL‐ASPECT Trial
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Background The hyperdense middle cerebral artery sign (HMCAS) observed on noncontrast computed tomography is associated with thrombus composition and thrombectomy outcomes. The impact of HMCAS on the efficacy of endovascular therapy (EVT) in patients with large core infarcts remains unclear. Methods This analysis uses data from the ANGEL‐ASPECT (Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients With a Large Infarct Core) trial, a multicenter randomized controlled trial conducted in China. Patients with acute ischemic stroke and anterior‐circulation large‐vessel occlusion were categorized according to whether HMCAS was present on baseline noncontrast computed tomography. The primary outcome was the 90‐day modified Rankin Scale score. Results Of the 432 patients included in this analysis, 33% were HMCAS positive on baseline noncontrast computed tomography. In the EVT‐treated patients, patients with HMCAS had worse functional outcomes than those without HMCAS (adjusted relative risk, 0.44 [95% CI, 0.26–0.73]; P =0.002). Patients with HMCAS required a greater number of thrombectomy passes ( P
Fields of Study & Subjects
Acute Ischemic Stroke Management
Intracranial Aneurysms: Treatment and Complications
Cerebrovascular and Carotid Artery Diseases
Publication details
- Journal / source
- Journal of the American Heart Association
- Volume
- 15
- Issue
- 7
- Pages
- e042473–e042473
- Publication date
- 31 March 2026
- Language
- EN